Musc Foundation for Research Development

Michael R Zile

Francis G Spinale

Robert E Stroud

Disclosed herein are methods of detecting and predicting diastolic heart failure and predicting congestive heart failure comprise protease and protease inhibitor profiling.

Detecting diastolic heart failure by protease and protease inhibitor plasma profiling

Disclosed are methods and materials for assessing cardiac failure, cardiac hypertrophy, and left ventricular remodeling using microRNA levels. The level of microRNAs can be measured in a body fluid, such as plasma and serum.

Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids

Disclosed herein are methods of detecting or predicting diastolic heart failure in a subject, comprising identifying a profile of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) from a body fluid of the subject that is associated herein with the existence of likely development of left ventricular dilation (LVD).

Growing community of inventors

Charleston, SC, United States of America

Michael R Zile